Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the ten brokerages that are currently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $48.67.
TEM has been the topic of a number of recent research reports. Morgan Stanley initiated coverage on shares of Tempus AI in a report on Tuesday, July 9th. They issued an “overweight” rating and a $44.00 target price on the stock. Loop Capital lifted their target price on shares of Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a report on Tuesday, October 15th. TD Cowen started coverage on shares of Tempus AI in a report on Tuesday, July 9th. They issued a “buy” rating and a $50.00 target price on the stock. Longbow Research started coverage on shares of Tempus AI in a research report on Tuesday, July 9th. They issued a “buy” rating and a $48.00 price objective on the stock. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Tempus AI from $42.00 to $47.00 and gave the company an “overweight” rating in a research report on Wednesday, August 7th.
View Our Latest Stock Report on TEM
Institutional Investors Weigh In On Tempus AI
Tempus AI Price Performance
TEM stock opened at $45.41 on Thursday. The company has a debt-to-equity ratio of 4.50, a quick ratio of 3.52 and a current ratio of 3.70. Tempus AI has a twelve month low of $22.89 and a twelve month high of $77.00. The business’s 50 day moving average is $52.71.
Tempus AI (NASDAQ:TEM – Get Free Report) last announced its earnings results on Tuesday, August 6th. The company reported ($6.77) EPS for the quarter, missing analysts’ consensus estimates of ($4.41) by ($2.36). The firm had revenue of $165.97 million for the quarter, compared to analyst estimates of $159.10 million. On average, equities research analysts expect that Tempus AI will post -6.51 earnings per share for the current fiscal year.
About Tempus AI
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Further Reading
- Five stocks we like better than Tempus AI
- Learn Technical Analysis Skills to Master the Stock Market
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- How to Calculate Inflation Rate
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- Investing in Travel Stocks Benefits
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.